Central Pharmaceutical CPC1 JSC

Central Pharmaceutical CPC1 JSC FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Central Pharmaceutical CPC1 JSC (DP1.VN) as of Nov 3, 2026 is 13.04 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was -21.91 % — a change of -159.50% (higher).

FCF Conversion

13.04 %

YoY

-159.50%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Central Pharmaceutical CPC1 JSC is 2024 13.04 % . FCF Conversion Rate (FCF/EBITDA) of Central Pharmaceutical CPC1 JSC was 2023 -21.91 % . It decreases by -159.50% higher compared to the previous year.

The Central Pharmaceutical CPC1 JSC FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2017
-830.33 VND
Jan 1, 2018
682.52 VND
Jan 1, 2019
770.83 VND
Jan 1, 2020
277.21 VND
Jan 1, 2021
179.98 VND
Jan 1, 2022
330.12 VND
Jan 1, 2023
-21.91 VND
Jan 1, 2024
13.04 VND
The Central Pharmaceutical CPC1 JSC FCF Conversion history
YEARFCF ConversionYoY
13.04 %-159.50%
-21.91 %-106.64%
330.12 %+83.42%
179.98 %-35.07%
277.21 %-64.04%
770.83 %+12.94%
682.52 %-182.20%
-830.33 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Central Pharmaceutical CPC1 JSC Stock analysis

What does Central Pharmaceutical CPC1 JSC do? Central Pharmaceutical CPC1 JSC is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Central Pharmaceutical CPC1 JSC stock

FCF Conversion Rate (FCF/EBITDA) of Central Pharmaceutical CPC1 JSC is 13.04 % in 2024.

FCF Conversion Rate (FCF/EBITDA) of Central Pharmaceutical CPC1 JSC changed from -21.91 % to 13.04 %, representing a -159.50% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Central Pharmaceutical CPC1 JSC since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Central Pharmaceutical CPC1 JSC with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — Central Pharmaceutical CPC1 JSC

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Central Pharmaceutical CPC1 JSC